Storia in 3 fonti

South Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant

The African Development Bank has finalised a $15 million loan for South Africa’s Biovac to build an end-to-end vaccine facility producing cholera, polio, pneumonia and meningitis vaccines

Raccontata da

iol.co.za

engineeringnews.co.za

africa.businessinsider.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

africa.businessinsider.comStai leggendo11 g fa

South Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant

The African Development Bank has finalised a $15 million loan for South Africa’s Biovac to build an end-to-end vaccine facility producing cholera, polio, pneumonia and meningitis vaccines

originale

iol.co.za12 g fa

African Development Bank backs Biovac with R250m to boost Africa's vaccine manufacturing

The African Development Bank has approved a $15 million loan to Biovac for a new vaccine manufacturing facility in Cape Town, enhancing Africa's vaccine production capacity and reducing reliance on imports.

Leggi questa versione →

South Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant

Confronto fonti

South Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant

African Development Bank backs Biovac with R250m to boost Africa's vaccine manufacturing

Timeline cronologica

African Development Bank backs Biovac with R250m to boost Africa's vaccine manufacturing

AfDB provides $15m to Biovac for new multi-vaccine production facility

AfDB provides $15m to Biovac for new multi-vaccine production facility

South Africa’s Biovac secures $15 million AfDB loan for Africa’s first end-to-end cholera vaccine plant